Mixing Russia's Sputnik V, AstraZeneca shots proves safe in small trial -RDIF

FILE PHOTO: A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov/File Photo

MOSCOW (Reuters) – Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca’s vaccine revealed no serious side effects among volunteers, the Russian Direct Investment Fund (RDIF) said on Friday.

The trial involved 50 people and began in Azerbaijan in February, RDIF, which is responsible for marketing Sputnik V vaccine abroad, said in the statement.

Source: Read Full Article

Related posts:
  1. Backers of WTO vaccine waiver ask opponents to join talks – document
  2. Russia reports record 737 COVID-19 deaths, changes entry rules
  3. Push to get wary Russians vaccinated leaves some COVID clinics short
  4. Brazil sees 108,732 new coronavirus cases, 1,324 deaths
  5. Italy recommends AstraZeneca COVID vaccine only for over-60s